9 Einträge gefunden

1. Baseline prevalence of erectile dysfunction in a prostate cancer screening population.

   1. Walz, Jochen
   2. Perrotte, Paul
   3. Suardi, Nazareno
   4. Hutterer, Georg
   5. Jeldres, Claudio
   6. Bénard, Francois
   7. Valiquette, Luc

   2008 - Forschungsinformationssystem des UKE
2. Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.

   1. Walz, Jochen
   2. Nazareno, Suardi
   3. Hutterer, Georg C
   4. Perrotte, Paul
   5. Gallina, Andrea
   6. Bénard, Francois
   7. Valiquette, Luc

   2008 - Forschungsinformationssystem des UKE
3. A nomogram predicting long-term biochemical recurrence after radical prostatectomy.

   1. Nazareno, Suardi
   2. Porter, Christopher R
   3. Reuther, Alwyn M
   4. Walz, Jochen
   5. Kodama, Koichi
   6. Gibbons, Robert P
   7. Correa, Roy

   2008 - Forschungsinformationssystem des UKE
4. Improved prediction of disease relapse after radical prostatectomy through a panel of preoperative blood-based biomarkers.

   1. Shariat, Shahrokh F
   2. Karam, Jose A
   3. Walz, Jochen
   4. Roehrborn, Claus G
   5. Montorsi, Francesco
   6. Margulis, Vitaly
   7. Saad, Fred

   2008 - Forschungsinformationssystem des UKE
5. Early postoperative plasma transforming growth factor-beta1 is a strong predictor of biochemical progression after radical prostatectomy.

   1. Shariat, Shahrokh F
   2. Walz, Jochen
   3. Roehrborn, Claus G
   4. Montorsi, Francesco
   5. Jeldres, Claudio
   6. Saad, Fred
   7. Karakiewicz, Pierre I

   2008 - Forschungsinformationssystem des UKE
6. Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.

   1. Jeldres, Claudio
   2. Suardi, Nazareno
   3. Walz, Jochen
   4. Saad, Fred
   5. Hutterer, Georg C
   6. Bhojani, Naeem
   7. Shariat, Shahrokh F

   2008 - Forschungsinformationssystem des UKE
7. High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer.

   1. Jeldres, Claudio
   2. Suardi, Nazareno
   3. Saad, Fred
   4. Montorsi, Francesco
   5. Shariat, Shahrokh F
   6. Perrotte, Paul
   7. Bhojani, Naeem

   2008 - Forschungsinformationssystem des UKE
8. Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.

   1. Walz, Jochen
   2. Haese, Alexander
   3. Scattoni, Vincenzo
   4. Steuber, Thomas
   5. Chun, Felix
   6. Briganti, Alberto
   7. Montorsi, Francesco

   2008 - Forschungsinformationssystem des UKE
9. The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases.

   1. Walz, Jochen
   2. Montorsi, Francesco
   3. Jeldres, Claudio
   4. Nazareno, Suardi
   5. Shariat, Shahrokh F
   6. Perrotte, Paul
   7. Arjane, Philippe

   2008 - Forschungsinformationssystem des UKE